Brian Jaczko

Brian Jaczko is a seasoned professional in the field of quality control and bioanalytical science, currently serving as the Head of Quality Control and Analytical Sciences & Technology at Novartis since June 2015. With previous roles as Associate Director and Principal Scientist, Brian has extensive experience analyzing in-process and final product samples under cGMP conditions, utilizing methods such as flow cytometry and cell-based assays in the development of CART-19 autologous oncology cell therapies. Prior to Novartis, Brian held positions at Dendreon Corporation, VaxInnate Corporation, ImClone Systems, Wyeth, and Ortho Clinical Diagnostics, contributing to various aspects of quality control and method development for oncology and immunotherapy products. Educational background includes studies at Virginia Tech.